Detalles de la búsqueda
1.
Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.
J Med Virol
; 88(2): 275-81, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26211752
2.
Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B.
Antimicrob Agents Chemother
; 59(2): 972-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25421484
3.
Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study.
Liver Int
; 35(10): 2246-55, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25682719
4.
Prospective cohort study on the outcomes of hepatitis C virus-related cirrhosis in South Korea.
J Gastroenterol Hepatol
; 30(8): 1281-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25778783
5.
Guggulsterone attenuates activation and survival of hepatic stellate cell by inhibiting nuclear factor kappa B activation and inducing apoptosis.
J Gastroenterol Hepatol
; 28(12): 1859-68, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23808824
6.
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
J Gastroenterol Hepatol
; 28(1): 128-34, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23033899
7.
Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: a prospective, multicenter, randomized, open-label study.
Scand J Gastroenterol
; 47(8-9): 1048-55, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22726105
8.
Serum HBsAg levels during peginterferon α-2a treatment with or without thymosin α-1 in HBeAg-positive chronic hepatitis B patients.
J Med Virol
; 83(1): 88-94, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21108343
9.
Low P2/MS value is an independent risk factor for early recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Hepatogastroenterology
; 58(105): 147-52, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21510303
10.
[24 weeks treatment with pegylated interferon alfa plus ribavirin may be possible in genotype 1 chronic hepatitis C patients with rapid virological response who have low pretreatment viremia].
Korean J Gastroenterol
; 56(1): 33-8, 2010 Jul.
Artículo
en Ko
| MEDLINE | ID: mdl-20664316
11.
Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.
J Pharmacol Exp Ther
; 330(1): 276-82, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19329756
12.
[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection].
Korean J Hepatol
; 14(3): 318-30, 2008 Sep.
Artículo
en Ko
| MEDLINE | ID: mdl-18815455
13.
[Short-term therapy with pegylated interferon plus ribavirin for the chronic hepatitis C genotype 2 patients].
Korean J Hepatol
; 13(3): 341-8, 2007 Sep.
Artículo
en Ko
| MEDLINE | ID: mdl-17898550
14.
Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea.
Gut Liver
; 11(3): 426-433, 2017 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28335101
15.
Geographic differences in the epidemiological features of HCV infection in Korea.
Clin Mol Hepatol
; 20(4): 361-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25548742
16.
[Clinical effects of bile aspiration just before contrast injection during endoscopic retrograde cholangiopancreatography].
Korean J Gastroenterol
; 60(6): 368-72, 2012 Dec.
Artículo
en Ko
| MEDLINE | ID: mdl-23242020
17.
Mesalamine-induced B7-H1 expression on hepatic stellate cells attenuates autoimmune liver injury.
Hepatol Res
; 41(1): 79-86, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20973884
18.
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin.
Korean J Hepatol
; 17(3): 183-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22102384
19.
Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
Cancer Lett
; 298(1): 9-15, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20573444
20.
Retinoic acid and its binding protein modulate apoptotic signals in hypoxic hepatocellular carcinoma cells.
Cancer Lett
; 295(2): 229-35, 2010 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350780
Resultados
1 -
20
de 20
1
Próxima >
>>